| Darshak M Sanghavi, MD | |
|
55 Lake Ave N, Department Of Pediatric Cardiology, Worcester, MA 01655-0002 | |
| (508) 856-4154 | |
| (508) 856-8125 |
| Full Name | Darshak M Sanghavi |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Cardiology |
| Location | 55 Lake Ave N, Worcester, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356394472 | NPI | - | NPPES |
| 2113732 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0202X | Pediatrics - Pediatric Cardiology | 207038 (Massachusetts) | Primary |
| Entity Name | Umass Memorial Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760445373 PECOS PAC ID: 4284539891 Enrollment ID: O20040113000267 |
News Archive
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) candidates for the treatment of cancer, respiratory and inflammatory diseases, announced today results from its randomized, placebo controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis.
Investigators at the Case Western Reserve University School of Medicine discovered that blocking interleukin-1α (IL1α), a protein that controls inflammation in the gut, markedly decreases the severity of intestinal inflammation in a mouse model of Crohn's disease (CD).
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that its president and CEO, Manish Singh Ph.D., will be presenting at the Immunotherapeutics Partnering and Deal Making Conference, which will take place in San Diego, California on January 30-31, 2012.
The COVID-19 pandemic has prompted a rapid expansion of telehealth use in the U.S. While articles have been published on telehealth and best practices for patient-centered communication during the crisis, none have focused on applying principles of trauma-informed care until now.
Researchers at the Albert Einstein College of Medicine of Yeshiva University have synthesized chemicals that are up to 10 times more effective than isoniazid, the leading anti-tuberculosis drug.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Darshak M Sanghavi, MD Po Box 415348, Boston, MA 02241-5348 Ph: (800) 225-8885 | Darshak M Sanghavi, MD 55 Lake Ave N, Department Of Pediatric Cardiology, Worcester, MA 01655-0002 Ph: (508) 856-4154 |
News Archive
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) candidates for the treatment of cancer, respiratory and inflammatory diseases, announced today results from its randomized, placebo controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis.
Investigators at the Case Western Reserve University School of Medicine discovered that blocking interleukin-1α (IL1α), a protein that controls inflammation in the gut, markedly decreases the severity of intestinal inflammation in a mouse model of Crohn's disease (CD).
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that its president and CEO, Manish Singh Ph.D., will be presenting at the Immunotherapeutics Partnering and Deal Making Conference, which will take place in San Diego, California on January 30-31, 2012.
The COVID-19 pandemic has prompted a rapid expansion of telehealth use in the U.S. While articles have been published on telehealth and best practices for patient-centered communication during the crisis, none have focused on applying principles of trauma-informed care until now.
Researchers at the Albert Einstein College of Medicine of Yeshiva University have synthesized chemicals that are up to 10 times more effective than isoniazid, the leading anti-tuberculosis drug.
› Verified 1 days ago
Marissa E Parrillo, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 774-442-5545 Fax: 774-443-7042 | |
Dr. Penny M. Feldman, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 774-441-8081 Fax: 774-441-8055 | |
Dr. Linda D Sagor, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Department Of Pediatrics, Worcester, MA 01655 Phone: 508-856-4198 Fax: 508-856-1042 | |
Dr. Robert W Zavoski, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 26 Queen Street, Worcester, MA 01610 Phone: 508-860-7800 Fax: 508-860-7925 | |
Cornelius T Tyrrell, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Department Of Pediatrics, Worcester, MA 01655 Phone: 508-334-7986 Fax: 508-334-7989 | |
Callie M Stone, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-1000 | |
Nura El-haj, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 774-441-8083 Fax: 774-441-8057 |